NeuroSense Therapeutics Ltd. - ORDINARY SHARES (NRSN)

Historical Portfolio Holders from Q4 2021 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / ORDINARY SHARES
Shares, excl. options Q2 2024
1.67M
Holdings value Q2 2024
$1.87M
Value change Q2 2024
+$1.61M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
7
Number of buys Q2 2024
2
Number of sells Q2 2024
-4
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 1.67M $1.87M +$1.61M $1.12 7
2024 Q1 167K $304K +$74.4K $1.82 8
2023 Q4 142K $111K -$461K $0.79 8
2023 Q3 779K $554K -$581K $0.71 5
2023 Q2 1.47M $2.2M +$2.01M $1.49 5
2023 Q1 124K $243K +$193K $1.74 5
2022 Q4 34.7K $41.6K -$46.6K $1.22 5
2022 Q3 73.7K $132K -$516K $1.80 4
2022 Q2 217K $733K +$131K $3.37 7
2022 Q1 159K $629K +$200K $3.83 6
2021 Q4 155K $380K +$380K $2.45 5